Candesartan cilexetil Prescribing at ROTHSCHILD HOUSE GROUP
Hypertension and heart failure | Cardiovascular System
Items (12m)
12,623
Total Quantity
380.2K
NHS Cost
£16.4K
vs National Avg
+963.8%
ROTHSCHILD HOUSE GROUP prescribed 12,623 items of Candesartan cilexetil over the last 12 months at a cost of £16,383 to the NHS. This is 963.8% above the national average prescribing rate. Candesartan cilexetil is classified under Hypertension and heart failure in the BNF.
Monthly Prescribing Trend
Jul 2026
1,118
Jul 2026
998
Jul 2026
1,156
Jul 2026
988
Jul 2026
1,050
Jul 2026
1,083
Jul 2026
979
Jul 2026
1,084
Jul 2026
1,122
Jul 2026
984
Jul 2026
999
Jul 2026
1,062
Prescribing Details
| Total Items | 12,623 |
|---|---|
| Total Quantity | 380,195 |
| Total NHS Cost | £16,383 |
| Presentations | 6 different forms |
| vs National Average | +963.8% |
Candesartan cilexetil Prescribing Comparison
| This practice | 12,623 items |
|---|---|
| National average per practice | 1,187 items |
| Difference | +963.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.